about
Race/ethnicity and disease severity in IgA nephropathyA randomized controlled trial of mycophenolate mofetil in patients with IgA nephropathy [ISRCTN62574616]Tandem repeats polymorphism of MUC20 is an independent factor for the progression of immunoglobulin A nephropathyA genome-wide association study in Han Chinese identifies multiple susceptibility loci for IgA nephropathyPredicting progression of IgA nephropathy: new clinical progression risk score.ACEI/ARB therapy for IgA nephropathy: a meta analysis of randomised controlled trials.Etiological profile of nephrotic syndrome in Kashmir.Steroids in the treatment of IgA nephropathy to the improvement of renal survival: a systematic review and meta-analysis.miR-34a regulates mesangial cell proliferation via the PDGFR-β/Ras-MAPK signaling pathway.The prevalence of immunologic injury in renal allograft recipients with de novo proteinuria.Combination therapy an ACE inhibitor and an angiotensin receptor blocker for IgA nephropathy: a meta-analysis.Variants of the ST6GALNAC2 promoter influence transcriptional activity and contribute to genetic susceptibility to IgA nephropathy.Efficacy and safety of mycophenolate mofetil treatment in IgA nephropathy: a systematic reviewReview of cases of IgA nephropathy.Military nephrology: magnitude of rates of deterioration in renal function.Variants in Complement Factor H and Complement Factor H-Related Protein Genes, CFHR3 and CFHR1, Affect Complement Activation in IgA NephropathyPlasma neutrophil gelatinase-associated lipocalin as a potential predictor of adverse renal outcomes in immunoglobulin A nephropathy.Promoters of Human Cosmc and T-synthase Genes Are Similar in Structure, Yet Different in Epigenetic RegulationLow Birth Weight and Risk of Progression to End Stage Renal Disease in IgA Nephropathy--A Retrospective Registry-Based Cohort Study.Serum galactose-deficient IgA1 level is not associated with proteinuria in children with IgA nephropathy.The level of galactose-deficient IgA1 in the sera of patients with IgA nephropathy is associated with disease progressionIgA Nephropathy in a Patient Presenting with Pseudotumor Cerebri.Comparison of effective impact among tonsillectomy alone, tonsillectomy combined with oral steroid and with steroid pulse therapy on long-term outcome of immunoglobulin A nephropathyThe genetics of IgA nephropathy.Urinary biomarkers of IgA nephropathy and other IgA-associated renal diseases.CD19+CD5+ B cells in primary IgA nephropathy.Continental variations in IgA nephropathy among AsiansPathogenetic significance of aberrant glycosylation of IgA1 in IgA nephropathy.Elevated Plasma α-Defensins (HNP1-3) Levels Correlated with IgA1 Glycosylation and Susceptibility to IgA NephropathyClinical and immunological implications of increase in CD208+ dendritic cells in tonsils of patients with immunoglobulin A nephropathy.Comparison of a Bayesian network with a logistic regression model to forecast IgA nephropathy.Changing prevalence of glomerular diseases in Korean adults: a review of 20 years of experience.The Tn antigen-structural simplicity and biological complexity.Tn and sialyl-Tn antigens, aberrant O-glycomics as human disease markers.Patterns of renal disease in South Korea: a 20-year review of a single-center renal biopsy database.Immunoglobulin A nephropathy: a pathophysiology view.Immunoglobulin a nephropathy: Pathological markers of renal survival in paediatric patients.Polymorphisms of the COL1A2, CYP1A1 and HS1,2 Ig enhancer genes in the Tuaregs from Libya.Frequency of familial Mediterranean fever (MEFV) gene mutations in patients with biopsy-proven primary glomerulonephritis.Mutations in the familial Mediterranean fever gene of patients with IgA nephropathy and other forms of glomerulonephritis.
P2860
Q24791691-26245051-6B9D-488E-BCB0-B5C959361B11Q24800133-2C5AF782-0D42-4734-8103-4E9E55E47364Q28299669-8CD49786-F3F9-47DB-95EB-870F97EF93DFQ28943427-72F99942-7C49-4A02-8427-387761997A99Q31068314-A349B63B-EF6D-46C9-B139-CB4CB4B3DDAFQ33458824-61DD6D72-D800-45C3-836B-B20140B1E627Q33762364-A57FC0CC-B74D-4788-AE4A-2CD48FDB32ECQ33886910-0DC61689-8A13-481A-BD51-CC19E4C12CABQ34243465-7734F2FD-1496-479E-BCFE-CE1D7C8F72DAQ34269169-3B0E8ED1-AC70-42D8-A1C2-CB55882ACE6FQ34418531-CB3DD390-5254-47F0-ADA5-AF5F39EC3356Q34625583-29DD25CA-2003-4F9D-A3CE-E619688D234EQ34709848-D43C15F8-3254-43E4-9D7C-68EF1C2C667DQ34747324-17042CE9-DF28-4976-8CDF-15DF09A3EEB2Q34747330-551E57E4-E88D-4050-AFE8-6C12A39A6560Q35550560-0FDB260E-23AC-47D9-B83E-112C6D001EAAQ35626252-2A78EF8B-5612-4867-B5C2-238E3B4BEF76Q35905327-5CA58E18-A085-485A-AA60-4E8CBA23B364Q35993496-FC63EF15-5612-412F-B61F-E6482F6EF5D8Q36057636-3946BC4D-8B72-45C3-995D-870773C1942DQ36237466-C1AF4F3D-F616-498F-8D67-4E168A91FECAQ36632837-F42C8781-8881-4D0E-9A6A-4B0E955933E3Q36767813-972E7222-C4E8-4B6E-90C4-A77E555DEA6FQ36831653-40E58272-2660-4F2E-A48D-AEB6096300B6Q36874248-8F149B2A-B0B0-4DB1-AB64-A1BEB350D95FQ36949221-75127FC1-8D51-4A8F-8242-12E29CA6C12BQ37108501-25603086-4092-4C30-8904-B2AF8300FE91Q37135384-E893851F-96DE-4EE4-890B-56C494210E57Q37176853-7CC374B7-23D1-4B59-A55B-647018781870Q37349702-44EA8F4D-6FF5-49BA-AB92-08B1F7A7965DQ37358315-D7B8AB90-2322-4F69-8ADE-972481A4B62AQ37407562-7051B374-91F8-4C67-9A7B-6CD0F71C5463Q37831859-6AA2200E-0630-4D77-BE8E-20E0D5F6E68BQ38121846-F1FAFEB7-1C09-48E7-92BF-AC1DE288EA4BQ38672489-754E3604-E1A7-4A4A-86DE-3A36B1C1C744Q38879517-BEFDB4ED-54FD-4269-BD26-716A43D7CD26Q38896208-BE0B96A8-9658-4348-88E9-723A20E459FAQ39219594-73C7E739-F6E9-4E0C-A44E-AA363EE37A6FQ40054594-323AE8B9-BCF8-4013-8944-BB1C56423667Q40430119-54CA6CB1-EBAC-4FBF-BBFA-4715B6BC159E
P2860
description
1988 nî lūn-bûn
@nan
1988年の論文
@ja
1988年論文
@yue
1988年論文
@zh-hant
1988年論文
@zh-hk
1988年論文
@zh-mo
1988年論文
@zh-tw
1988年论文
@wuu
1988年论文
@zh
1988年论文
@zh-cn
name
Worldwide perspective of IgA nephropathy.
@en
Worldwide perspective of IgA nephropathy.
@nl
type
label
Worldwide perspective of IgA nephropathy.
@en
Worldwide perspective of IgA nephropathy.
@nl
prefLabel
Worldwide perspective of IgA nephropathy.
@en
Worldwide perspective of IgA nephropathy.
@nl
P1476
Worldwide perspective of IgA nephropathy.
@en
P304
P356
10.1016/S0272-6386(88)80021-0
P577
1988-11-01T00:00:00Z